Terns Pharmaceuticals Inc (TERN) Company Profile & Statistics

Terns Pharmaceuticals Inc
TERN
(Nasdaq - US)
Open
5.93
+0.14 (+2.42%)
in:usd•As of: Nov 25, 2024 09:47 UTC -5
Open
5.92
High
5.97
Low
5.90

About Terns Pharmaceuticals Inc

CEO

Amy Burroughs

Headquarters

1065 east hillsdale blvd., suite 100

foster city, ca 94404, united states

Auditor

Ernst & Young LLP

Employees

Share Holders

Website

www.ternspharma.com

Industry

biotechnology

Sector

health technology

Company Overview

Terns Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company. It engages in development of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis and other chronic liver diseases. Terns Pharmaceuticals Inc. is based in FOSTER CITY, Calif.

Terns Pharmaceuticals Inc Statistics

Valuation Measures

Market Capitalization ²	503.69M
Enterprise Value	233.56M
Enterprise Value/EBITDA (ttm)	-2.24
Price to Earnings Ratio (ttm)	N/A
Price to Book (mrq)	1.12
Price to Sales (ttm)	N/A
Price to Cash (ytd)	N/A

Profitability

Gross Margin (ttm)	0.00%
Operating Margin (ttm)	N/A
Profit Margin (ttm)	0.00%
Return on Equity (ttm)	-32.76%
Return on Invested Capital (ttm)	-34.10%
Return on Assets (ttm)	-31.33%

Income Statement

Revenue (ttm)	0.00
Revenue Per Share (ttm)	0.00
Gross Profit (ttm)	0.00
EBITDA (ttm)³	-104.11M
Net Income Avi to Common (ttm)	-88.07M
Diluted EPS (ttm)	-1.18

Share Statistics

Beta (5Y Monthly)	-0.32
52-Week Change	58.13%
S&P500 52-Week Change	32.11%
S&P500 Member	No
Stock Optionable	Yes
Total Shares Outstanding ¹	84.94M
Dividend Yield	0.00%
Float ⁴	72.11M
% Held by Insiders	15.10%
% Held by Institutions	98.26%

Balance Sheet

Total Cash (mrq)	372.78M
Total Cash Per Share (mrq)	4.39
Total Debt (mrq)	0.00
Total Debt/Equity (mrq)	0.00%
Current Ratio (mrq)	32.99%
Quick Ratio (mrq)	32.99%
Book Value Per Share (mrq)	4.29

Cash Flow

Operating Cash Flow Per Share (ytd)	-0.71
Free Cash Flow (ytd)	-55.47M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. Stock price provided by Xignite. All numbers are rounded to the closest decimal.

¹ Total Shares outstanding is taken from the most recently filed quarterly or annual report.

² Market Cap is calculated using total shares outstanding and the most recent share price.

³ EBITDA is calculated using methodology that may differ from that used by a company in its reporting.

⁴ The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

Terns Pharmaceuticals Inc

Trade With A Regulated Broker